Madrigal Pharmaceuticals Inc (OQ:MDGL)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEC
Company Contact
Address: 200 Barr Harbor Dr Ste 400
WEST CONSHOHOCKEN PA 19428-2978
Tel: N/A
Website: https://www.madrigalpharma.com
IR: See website
<
Key People
Bill Sibold
President, Chief Executive Officer, Director
Mardi C. Dier
Chief Financial Officer, Senior Vice President
Rebecca A. Taub
President of Research and Development, Chief Medical Officer, Director
Brian J. Lynch
Senior Vice President, General Counsel
Ronald Filippo
Chief Information Officer
Carole Huntsman
Chief Commercial Officer
Robert Waltermire
Chief Pharmaceutical Development Officer
   
Business Overview
N/A
Financial Overview
For the fiscal year ended 31 December 2023, Madrigal Pharmaceuticals Inc revenues was not reported. Net loss increased 27% to $373.6M. Higher net loss reflects G & A increase from $30.4M to $79.3M (expense), R & D increase of 9% to $251.5M (expense), Stock-based Compensation in SGA increase of 63% to $28.9M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$17.23 to -$19.99.
Employees: 376 as of Feb 22, 2024
Reporting Currency: U.S. Dollars
Enterprise value: $4,819M as of Dec 31, 2023
Annual revenue (TTM): $0.00M as of Dec 31, 2023
EBITDA (TTM): -$379.97M as of Dec 31, 2023
Net annual income (TTM): -$373.63M as of Dec 31, 2023
Free cash flow (TTM): -$325.71M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 20,625,427 as of Mar 18, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.